Harris has been awarded a 5-year, $43 million follow-on contract by the National Cancer Institute's Center for Cancer Research, continuing a legacy of providing comprehensive clinical data management for the Institute's intramural clinical trials program. The contract, which includes one base year and four one-year options, was awarded during the first quarter of Harris’ fiscal 2017.

Harris will continue to provide the expertise that drove increased data volume capacity and upheld high data quality within funding expectations under past contracts. This includes clinical data management, quality assurance and control, clinical audit and monitoring clinical trials for safety and compliance as well as research databases and systems enhancement.

"The Harris team has consistently delivered increased data accuracy and improved program efficiencies for the National Cancer Institute for nearly 35 years," said Carl D’Alessandro, president, Harris Critical Networks. "Harris will build on this long legacy of innovation to deliver accurate and timely clinical data management support in full compliance with federal regulations."